Search Within

Myeloma

Formats
  1. Meeting Abstract (546)
  2. Journal Article (358)
  3. Review (36)
  4. Research Letter (20)
  5. Book Section (10)
  6. Guidelines (10)
  7. Correspondence (6)
  8. Editorial (5)
  9. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (992)
  2. Department of Medicine (992)
  3. Hematologic Malignancies, Division of (992)
  4. Hematologic Malignancies Research (653)
  5. Survivorship Research (359)
  6. Sloan Kettering Institute Postdocs (293)

More Groups

People
  1. Alexander Lesokhin (365)
  2. Carl Landgren (336)
  3. Hani Hassoun (330)
  4. Sham Mailankody (284)
  5. Malin Hultcrantz (261)
  6. Heather Landau (240)

More People

Years
  1. 2025 (14)
  2. 2024 (72)
  3. 2023 (115)
  4. 2022 (96)
  5. 2021 (76)
  6. 2020 (95)

More Years

Publications
  1. Blood (306)
  2. Clinical Lymphoma, Myeloma and Leukemia (96)
  3. Journal of Clinical Oncology (85)
  4. Haematologica (41)
  5. Biology of Blood and Marrow Transplantation (29)
  6. Blood Cancer Journal (22)

More Publications

Publishers
  1. American Society of Hematology (327)
  2. Elsevier Inc. (159)
  3. American Society of Clinical Oncology (87)
  4. Nature Publishing Group (83)
  5. Ferrata Storti Foundation (41)
  6. American Association for Cancer Research (34)

More Publishers

Results (992)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survival, response duration, and activity by BRAF mutation (MT) status in a phase 1 trial of nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL)
    Meeting Abstract

    Kluger, H.; Sznol, M.; Callahan, M.; Postow, M.; Gordon, R.; Segal, N. H.; Rizvi, N.; Lesokhin, A.; Atkins, M. B.; Kirkwood, J.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • The road to treating smoldering multiple myeloma
    Conference Paper

    Korde, N.; Mailankody, S.; Landgren, O.
    Elsevier Inc. (2014)

    Fulltext@MSK | Save
  • Successful perioperative use of prothrombin complex concentrate in the treatment of acquired factor X deficiency in the setting of systemic light-chain (AL) amyloidosis
    Journal Article

    Litvak, A.; Kumar, A.; Wong, R. J.; Smith, L.; Hassoun, H.; Soff, G.
    American Journal of Hematology (2014)

    Fulltext@MSK | Save
  • Elevated risk of venous but not arterial thrombosis in Waldenström macroglobulinemia/lymphoplasmacytic lymphoma
    Journal Article

    Hultcrantz, M.; Pfeiffer, R. M.; Björkholm, M.; Goldin, L. R.; Turesson, I.; Schulman, S.; Landgren, O.; Kristinsson, S. Y.
    Journal of Thrombosis and Haemostasis (2014)

    Fulltext@MSK | Save
  • Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-programmed death-1) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL)
    Meeting Abstract

    Sznol, M.; Kluger, H.; Callahan, M. K.; Postow, M. A.; Gordon, R.; Seal, N. H.; Rizvi, N. A.; Lesokhin, A. M.; Atkins, M. B.; Kirkwood, J. M.; more...
    Asia-Pacific Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Smoldering multiple myeloma: Special considerations surrounding treatment on versus off clinical trials
    Journal Article

    Manasanch, E. E.; Korde, N.; Mailankody, S.; Tageja, N.; Bhutani, M.; Roschewski, M.; Landgren, O.
    Haematologica (2014)

    Fulltext@MSK | Save
  • How I treat smoldering multiple myeloma
    Journal Article

    Ghobrial, I. M.; Landgren, O.
    Blood (2014)

    Fulltext@MSK | Save
  • A phase Ib dose escalation trial of sar650984 (anti-cd-38 mab) in combination with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma
    Meeting Abstract

    Martin, T.; Baz, R.; Benson, D.; Lendvai, N.; Vij, R.; Charpentier, E.; Hsu, K.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Harnessing the immune system for cancer therapy
    Journal Article

    Smith, E. L.; Zamarin, D.; Lesokhin, A. M.
    Current Opinion in Oncology (2014)

    Fulltext@MSK | Save
  • International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
    Journal Article

    Rajkumar, S. V.; Dimopoulos, M. A.; Palumbo, A.; Blade, J.; Merlini, G.; Mateos, M. V.; Kumar, S.; Hillengass, J.; Kastritis, E.; Richardson, P.; more...
    Lancet Oncology (2014)

    Fulltext@MSK | Save